206 related articles for article (PubMed ID: 19418582)
1. Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation.
Renga B; Mencarelli A; Migliorati M; Distrutti E; Fiorucci S
World J Gastroenterol; 2009 May; 15(17):2097-108. PubMed ID: 19418582
[TBL] [Abstract][Full Text] [Related]
2. Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertension.
Fiorucci S; Distrutti E
Pharmacol Res; 2016 Sep; 111():749-756. PubMed ID: 27475883
[TBL] [Abstract][Full Text] [Related]
3. Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids.
Renga B; Bucci M; Cipriani S; Carino A; Monti MC; Zampella A; Gargiulo A; d'Emmanuele di Villa Bianca R; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H114-26. PubMed ID: 25934094
[TBL] [Abstract][Full Text] [Related]
4. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
5. Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1.
Renga B; Cipriani S; Carino A; Simonetti M; Zampella A; Fiorucci S
PLoS One; 2015; 10(11):e0141082. PubMed ID: 26539823
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor.
Xu W; Cui C; Cui C; Chen Z; Zhang H; Cui Q; Xu G; Fan J; Han Y; Tang L; Targher G; Byrne CD; Zheng MH; Yang L; Cai J; Geng B
Hepatology; 2022 Dec; 76(6):1794-1810. PubMed ID: 35586979
[TBL] [Abstract][Full Text] [Related]
7. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.
Kast HR; Goodwin B; Tarr PT; Jones SA; Anisfeld AM; Stoltz CM; Tontonoz P; Kliewer S; Willson TM; Edwards PA
J Biol Chem; 2002 Jan; 277(4):2908-15. PubMed ID: 11706036
[TBL] [Abstract][Full Text] [Related]
8. Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators.
Fiorucci S; Zampella A; Cirino G; Bucci M; Distrutti E
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H21-H32. PubMed ID: 27765751
[TBL] [Abstract][Full Text] [Related]
9. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide generation in mammals: the molecular biology of cystathionine-β- synthase (CBS) and cystathionine-γ-lyase (CSE).
Renga B
Inflamm Allergy Drug Targets; 2011 Apr; 10(2):85-91. PubMed ID: 21275900
[TBL] [Abstract][Full Text] [Related]
12. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S
Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598
[TBL] [Abstract][Full Text] [Related]
13. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
Massafra V; Milona A; Vos HR; Ramos RJJ; Gerrits J; Willemsen ECL; Ramos Pittol JM; Ijssennagger N; Houweling M; Prinsen HCMT; Verhoeven-Duif NM; Burgering BMT; van Mil SWC
Gastroenterology; 2017 May; 152(6):1462-1476.e10. PubMed ID: 28130067
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity, liver cirrhosis and portal hypertension in rats.
Tan G; Pan S; Li J; Dong X; Kang K; Zhao M; Jiang X; Kanwar JR; Qiao H; Jiang H; Sun X
PLoS One; 2011; 6(10):e25943. PubMed ID: 22022478
[TBL] [Abstract][Full Text] [Related]
15. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
[TBL] [Abstract][Full Text] [Related]
17. The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis.
Fiorucci S; Antonelli E; Mencarelli A; Orlandi S; Renga B; Rizzo G; Distrutti E; Shah V; Morelli A
Hepatology; 2005 Sep; 42(3):539-48. PubMed ID: 16108046
[TBL] [Abstract][Full Text] [Related]
18. Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1.
Hoeke MO; Heegsma J; Hoekstra M; Moshage H; Faber KN
PLoS One; 2014; 9(2):e88011. PubMed ID: 24498423
[TBL] [Abstract][Full Text] [Related]
19. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
Erichsen TJ; Aehlen A; Ehmer U; Kalthoff S; Manns MP; Strassburg CP
J Hepatol; 2010 Apr; 52(4):570-8. PubMed ID: 20189675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
